Yliopiston etusivulle In English
University of Helsinki
 

Hautaniemi Lab

Laboratory information:

Contact information:

Sampsa Hautaniemi
Biomedicum Helsinki, B524b
P.O.Box 63 (Haartmaninkatu 8)
00014 UNIVERSITY OF HELSINKI
phone +358 9 191 25419
fax +358 9 191 25610

firstname.lastname@helsinki.fi

Publications

tehostekuva All articles are available directly or upon request.

Articles from work at University of Helsinki (Spring 2006 -- )

2013

  • Carlsson E, Krohn K, Ovaska K, Lindberg P, Häyry V, Maliniemi P, Lintulahti A, Korja M, Kivisaari R, Hussein S, Sarna S, Niiranen K, Hautaniemi S, Haapasalo H, Ranki A.
    Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis
    Genes, Choromosomes and Cancer, 2013 Feb;52(2):191-201.
    [pdf]

2012

  • Merkin J, Russell C, Chen P, Burge CB.
    Evolutionary dynamics of gene and isoform regulation in mammalian tissues
    Science, 2012 Dec 21;338(6114):1593-9.
    [link to pdf]

  • Sahu B, Laakso M, Pihlajamaa P, Ovaska K, Sinielnikov I, Hautaniemi S, Jänne O.
    FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells
    Cancer Research, 2012 Dec 26, E-pub ahead of print.
    [pdf] [Anduril report]

  • Ovaska K, Lyly L, Sahu B, Jänne O, Hautaniemi S.
    Genomic region operation kit for flexible processing of deep sequencing data
    IEEE/ACM Transactions on Computational Biology and Bioinformatics, 2012 Dec 28, E-pub ahead of print.
    [pdf]

  • Jamshidi M, Schmidt MK, Dörk T, Garcia-Closas M, Heikkinen T, Cornelissen S, van den Broek AJ, Schürmann P, Meyer A, Park-Simon TW, Figueroa J, Sherman M, Lissowska J, Keong GT, Irwanto A, Laakso M, Hautaniemi S, Aittomäki K, Blomqvist C, Liu J, Nevanlinna H.
    Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome
    International Journal of Cancer, 2012 Oct 4, E-pub ahead of print.
    [pdf]

  • Mustjoki S, Auvinen K, Kreutzman A, Rousselot P, Hernesniemi S, Melo T, Lahesmaa-Korpinen A-M, Hautaniemi S, Bouchet S, Molimard M, Smykla R, Lee FY, Vakkila J, Jalkanen S, Salmi M, Porkka K.
    Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy in leukemia patients
    Leukemia, in press.

  • Karhemo PR, Ravela S, Laakso M, Ritamo I, Tatti O, Mäkinen S, Goodison S, Stenman UH, Hölttä E, Hautaniemi S, Valmu L, Lehti K, Laakkonen P.
    An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis
    Journal of Proteomics, 2012 Dec 21;77:87-100.
    [pdf]

  • Jalkanen SE, Lahesmaa-Korpinen A-M, Heckman CA, Rantanen V, Porkka K, Hautaniemi S, Mustjoki S.
    Phosphoprotein profiling predicts response to tyrosine kinase inhibitor therapy in chronic myeloid leukemia patients.
    Experimental Hematology, 2012 Sep;40(9):705-714.e3.
    [pdf]

  • Hu Y, Ylivinkka I, Chen P, Li L, Hautaniemi S, Nyman TA, Keski-Oja J, Hyytiäinen M.
    Netrin-4 promotes glioblastoma cell proliferation via integrin beta-4 signaling
    Neoplasia, 2012 Mar; 14(3): 219-227.
    [pdf]

  • Karinen S, Saarinen S, Lehtonen R, Rastas P, Vahteristo P, Aaltonen L A, Hautaniemi S.
    Rule-based induction method for haplotype comparison and identification of candidate disease loci
    Genome Medicine, 2012 Mar 19;4(3):21.
    [pdf]

  • Louhimo R, Lepikhova T, Monni O, Hautaniemi S.
    Comparative analysis of algorithms for integration of copy number and expression data
    Nature Methods, 2012 Feb; 9(4):351-5.
    [pdf]

  • Rafn B, Friberg Nielsen C, Hagel Andersen S, Szyniarowski P, Corcelle-Termeau E, Valo E, Fehrenbacher N, Olsen C, Daugaard M, Egebjerg C, Bøttzauw T, Kohonen P, Nylandsted J, Hautaniemi S, Moreira J, Jäättelä M, Kallunki T.
    ErbB2-driven breast cancer cell invasion depends on a complex signaling network activating myeloid zinc finger-1-dependent cathepsin B expression
    Molecular Cell, 2012 Mar; 45(6):764-76.
    [pdf]

  • Tuupanen S, Yan J, Turunen M, Gylfe A, Kaasinen E, Li L, Eng C, Culver D, Kalady M, Pennison M, Paschke B, de la Chapelle A, Hampel H, Henderson B, Le Marchand L, Hautaniemi S, Askhtorab H, Smoot D, Sandler R, Keku T, Kupfer S, Ellis N, Haiman C, Taipale T, Aaltonen LA.
    Characterization of the colorectal cancer associated enhancer MYC-335 at 8q24: the role of rs67491583
    Cancer Genetics, 2012 Jan; 205(1-2):25-33.
    [pdf]

  • Niemelä M, Kauko O, Sihto H, Mpindi JP, Nicorici D, Pernilä P, Kallioniemi OP, Joensuu H, Hautaniemi S, Westermarck J.
    CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes
    Oncogene, 2012 Sep 27;31(39):4266-78.
    [pdf]

  • Mathiasen D, Egebjerg C, Khanna A, Daugaard M, Rafn B, Bøttzauw T, Friberg C, Tuomela S, Valo E, Willumsen B, Hautaniemi S, Lahesmaa R, Westermarck J, Jäättelä M, Kallunki T.
    Identification of a c-Jun N-terminal kinase 2 dependent signal amplification cascade that regulates c-Myc levels in Ras transformation
    Oncogene, 2012 Jan 19;31(3):390-40.
    [pdf]

  • Balestrieri C, Vanoni M, Hautaniemi S, Alberghina L, Chiaradonna F.
    Integrative transcriptional analysis between human and mouse cancer cells provides a common set of transformation associated genes
    Biotechnology Advances, 2012 Jan-Feb;30(1):16-29.
    [pdf]

  • Alhopuro P, Sammalkorpi H, Niittymäki I, Biström M, Raitila A, Saharinen J, Nousiainen K, Lehtonen HJ, Heliövaara E, Puhakka J, Tuupanen S, Sousa S, Seruca R, Ferreira AM, Hofstra RM, Mecklin JP, Järvinen H, Ristimäki A, Orntoft TF, Hautaniemi S, Arango D, Karhu A, Aaltonen LA.
    Candidate driver genes in microsatellite-unstable colorectal cancer
    International Journal of Cancer, 2012 Apr 1;130(7):1558-66.
    [pdf]

2011

  • Cheng F, Pekkonen P, Laurinavicius S, Sugiyama N, Henderson S, Gunther T, Rantanen V, Kaivanto E, Aavikko M, Sarek G, Hautaniemi S, Biberfeld P, Aaltonen LA, Grundhoff A, Boshoff C, Alitalo K, Lehti K, and Ojala P.
    KSHV-Initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition
    Cell Host & Microbe, 2011 Dec 15; 10(6):577-590.
    [pdf]

  • Lahesmaa-Korpinen AM, Jalkanen SE, Chen P, Valo E, Núñez-Fontarnau J, Rantanen V, Oghabian A, Vakkila J, Porkka K, Mustjoki S, Hautaniemi S.
    FlowAnd: Comprehensive computational framework for flow cytometry data analysis

    Journal of Proteomics and Bioinformatics
    , 2011 Nov 4: 245-249.
    [pdf]

  • Rodriguez-Martinez A, Alarmo EL, Saarinen L, Ketolainen J, Nousiainen K, Hautaniemi S, Kallioniemi A.
    Analysis of BMP4 and BMP7 signaling in breast cancer cells unveils time-dependent transcription patterns and highlights a common synexpression group of genes
    BMC Medical Genomics, 2011 Nov 25;4:80.
    [pdf]

  • Cowley MJ, Pinese M, Kassahn KS, Waddell N, Pearson JV, Grimmond SM, Biankin AV, Hautaniemi S, Wu J.
    PINA v2.0: mining interactome modules
    Nucleic Acids Research. 2011 Nov 8. 2012 Jan;40(Database issue):D862-5.
    [pdf]

  • Habermann JK, Bundgen NK, Gemoll T, Hautaniemi S, Lundgren C, Wangsa D, Doering J, Bruch HP, Nordstroem B, Roblick UJ, Jornvall H, Auer G, Ried T.
    Genomic instability influences the transcriptome and proteome in endometrial cancer subtypes
    Molecular Cancer. 2011 Oct 31;10(1):132.
    [pdf]

  • Maliniemi P, Carlsson E, Kaukola A, Ovaska K, Niiranen K, Saksela O, Jeskanen L, Hautaniemi S, Ranki A.
    NAV3 copy number changes and target genes in basal and squamous cell cancers
    Experimental Dermatology. 2011 Nov;20(11):926-31.
    [pdf]

  • Sahu B, Laakso M, Ovaska K, Mirtti T, Lundin J, Rannikko A, Sankila A, Turunen JP, Lundin M, Konsti J, Vesterinen T, Nordling S, Kallioniemi O, Hautaniemi S, Jänne O.
    Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signaling and prostate cancer
    EMBO Journal,2011 Sep 13;30(19):3962-76.
    [pdf] [Anduril report]

  • Pihlajamaa P, Zhang FP, Saarinen L, Mikkonen L, Hautaniemi S, Jänne O.
    The phytoestrogen genistein is a tissue-specific androgen receptor modulator
    Endocrinology, 2011 Nov;152(11):4395-405.
    [pdf]

  • Chen P, Lepikhova T, Hu YZ, Monni O and Hautaniemi S.
    Comprehensive exon array data processing method for quantitative analysis of alternative spliced variants
    Nucleic Acids Research, 2011 Oct;39(18):e123.
    [pdf] [website]

  • Heinonen M, Hemmes A, Salmenkivi K, Abdelmohsen K, Vilén ST, Laakso M, Leidenius M, Salo T, Hautaniemi S, Gorospe M, Heikkilä P, Haglund C, Ristimäki A.
    Role of RNA binding protein HuR in ductal carcinoma in situ of the breast
    The Journal of Pathology, 2011 Mar 7.
    [pdf]

  • Karinen S, Heikkinen T, Nevanlinna H, Hautaniemi S.
    Data integration workflow for search of disease driving genes and genetic variants
    PLoS ONE, 2011 Apr; 6(4).
    [pdf] [website]

  • Louhimo R, Hautaniemi S.
    CNAmet: an R package for integrating copy number, methylation and expression data
    Bioinformatics, 2011 Mar 15;27(6):887-8.
    [pdf] [website]

  • Koivula S, Valo E, Raunio A, Hautaniemi S, Leppä S.
    Rituximab regulates signaling pathways and alters gene expression associated with cell death and survival in diffuse large B-cell lymphoma
    Oncology Reports, 2011 Apr;25(4):1183-90.
    [pdf]

  • Niittymäki I, Gylfe A, Laine L, Laakso M, HJ Lehtonen, Kondelin J, Tolvanen J, Nousiainen K, Pouwels J, Järvinen H, Nuorva K, Mecklin JP, Mäkinen M, Ristimäki A, Ørntoft TF, Hautaniemi S, Karhu A, Kallio MJ, Aaltonen LA.
    High frequency of TTK mutations in microsatellite-unstable colorectal cancer and evaluation of their effect on spindle-assembly checkpoint
    Carcinogenesis, 2011 Mar;32(3):305-11.
    [pdf]

2010

  • Ovaska K, Laakso M, Haapa-Paananen S, Louhimo R, Chen P, Aittomäki V, Valo E, Nunez-Fontarnau J, Rantanen V, Karinen S, Nousiainen K, Lahesmaa-Korpinen A-M, Miettinen M, Saarinen L, Kohonen P, Wu J, Westermarck J, Hautaniemi S.
    Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme
    Genome Medicine, 2010, 2:65.
    [pdf] [website] [results website] [commentary]

  • Lahesmaa-Korpinen A-M, Carlson SM, White FM, Hautaniemi S.
    Integrated data management and validation platform for phosphorylated tandem mass spectrometry data
    Proteomics, 2010 Oct;10(19):3515-24.
    [pdf]

  • Laakso M, Hautaniemi S.
    Integrative platform to translate gene sets to networks
    Bioinformatics, 2010 Jul 15;26(14):1802-3.
    [pdf] [download]

  • Alhopuro P, Björklund M, Sammalkorpi H, Turunen M, Tuupanen S, Biström M,
    Niittymäki I, Lehtonen HJ, Kivioja T, Launonen V, Saharinen J, Nousiainen
    K, Hautaniemi S, Nuorva K, Mecklin JP, Järvinen H, Orntoft T, Arango D,
    Lehtonen R, Karhu A, Taipale J, Aaltonen LA.
    Mutations in the circadian gene CLOCK in colorectal cancer
    Molecular Cancer Research, 2010 Jul;8(7):952-60.
    [pdf]

  • Taskinen M, Valo E, Karjalainen-Lindsberg ML, Hautaniemi S, Meri S, Leppä S.
    Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP
    Clinical Cancer Research, 2010 May 1;16(9):2615-23.
    [pdf]

  • Savilahti EM, Karinen S, Salo H, Klemetti P, Saarinen KM, Klemola T, Kuitunen M, Hautaniemi S, Savilahti E, Vaarala O.
    Combined T regulatory cell and Th2 expression profile identifies children with cow's milk allergy
    Clinical Immunology, 2010 Jul;136(1):16-20.
    [pdf]

  • Savilahti EM, Rantanen V, Lin J, Karinen S, Saarinen KM, Goldis M, Mäkelä M, Hautaniemi S, Savilahti E, Sampson H.
    Early recovery from cow's milk allergy is associated with decreasing IgE and increasing IgG4 binding to cow's milk epitopes
    Journal of Allergy and Clinical Immunology, 2010 Jun;125(6):1315-1321.
    [pdf]

2009

  • Rajecki M, Hällström TA, Hakkarainen T, Nokisalmi P, Hautaniemi S, Nieminen AI, Tenhunen M, Rantanen V, Desmond RA, Chen DT, Guse K, Stenman UH, Gargini R, Kapanen M, Klefström J, Kanerva A, Pesonen S, Ahtiainen L, Hemminki A.
    Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiation
    International Journal of Cancer 2009 Jun 2;125(10):2441-2449.
    [pdf]

  • Blomster HA, Hietakangas V, Wu J, Kouvonen P, Hautaniemi S, Sistonen L.
    Novel proteomics strategy brings insight into the prevalence of SUMO-2 target sites
    Molecular & Cellular Proteomics 2009 Jun;8(6):1382-90.
    [pdf]

  • Backlund M, Paukku K, Daviet L, De Boer R, Kalkkinen N, Valo E, Hautaniemi S, Ehsan A, Kontula K, Lehtonen J.
    Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase
    Nucleic Acids Research 2009 Apr;37(7):2346-58.
    [pdf]

  • Wu J, Vallenius T, Ovaska K, Westermarck J, Mäkelä TP, Hautaniemi S.
    Integrated network analysis platform for protein-protein interactions
    Nature Methods 2009 Jan;6(1):75-77.
    [pdf] [web site]

  • Habermann J, Doering J, Hautaniemi S, Roblick W, Bündgen N, Nicorici D, Kronenwett U, Rathnagiriswaran S, Mettu TK, Ma Y, Krüger S, Bruch HP, Auer G, Guo NL, Ried T.
    The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome
    International Journal of Cancer 2009 Apr 1;124(7):1552-64.
    [pdf]

2008


  • Ovaska K, Laakso M, Hautaniemi S.
    Fast Gene Ontology based clustering for microarray experiments
    BioData Mining 2008 Nov 21;1(1):11.
    [pdf] [download]

  • Kilpinen S, Autio R, Ojala K, Iljin K, Bucher E, Sara H, Pisto T, Saarela M, Skotheim RI, Björkman M, Mpindi JP, Edgren H, Wolf M, Astola J, Nees M, Hautaniemi S, Kallioniemi O.
    Systematic bioinformatic analysis of expression levels of 17330 human genes across 9783 samples from 175 types of healthy and pathological tissues
    Genome Biology 2008 Sep 9:R139.
    [pdf] [web site]

  • Nieminen H, Nieminen A, Saarela M, Kallioniemi A, Klefström J, Hautaniemi S, Monni O.
    Deciphering downstream gene targets of p70S6 kinase in breast cancer
    BMC Genomics 2008 Jul 24;9(1):348.
    [pdf]

  • Tuupanen S, Niittymäki I, Nousiainen K, Vanharanta S, Mecklin JP, Nuorva K, Järvinen H, Hautaniemi S, Karhu A, Aaltonen LA.
    Allelic imbalance at rs6983267 suggests selection of the risk allele in somatic CRC tumor evolution
    Cancer Research 2008 Jan 1;68(1):14-7.
    [pdf]

2007


  • Laakso M, Tuupanen S, Karhu A, Lehtonen R, Aaltonen LA, Hautaniemi S.
    Computational identification of candidate loci for recessively inherited mutation using high throughput SNP arrays
    Bioinformatics 2007 Aug 1;23(15):1952-61.
    [pdf] [download]

  • Wolf-Yadlin A, Hautaniemi S, Lauffenburger DA, White FM.
    Multiple reaction monitoring for robust quantitative analysis of cellular signaling networks
    Proc Natl Acad Sci U S A 2007 Apr;104(14):5860-65.
    [pdf]

  • Kharait S, Hautaniemi S, Wu S, Iwabu A, Lauffenburger DA, Wells A.
    Decision tree analysis predicts quantitative effects of contractility signaling on cell motility
    BMC Systems Biology 2007 Jan;1:9.
    [pdf]

2006


  • Hemmoranta H, Hautaniemi S, Niemi J, Nicorici D, Laine J, Yli-Harja O, Partanen J, Jaatinen T.
    Transcriptional profiling reflects shared and unique characters for CD34+ and CD133+ cells
    Stem Cells and Development 2006 Dec;15(6):839-51.
    [pdf]

  • Hautaniemi S, Vallenius T, Mäkelä T.
    Systems biology in cancer research
    Duodecim 2006 Nov;122(20):2484-90.
    [pdf] (in Finnish)


Articles from work during post-doctoral research (MIT, 2004-2006), research visit (NHGRI, NIH, 2001-2002) and graduate research (Tampere University of Technology, 2001-2003)

  • Wolf-Yadlin A, Kumar N, Zhang Y, Hautaniemi S, Zaman M, Kim HD, Grantcharova V, Lauffenburger DA, White FM.
    HER2-overexpression effects on cell signaling networks governing proliferation and migration
    Molecular Systems Biology 2006 Oct;2:54.
    [pdf]

  • Hua F, Hautaniemi S, Yokoo R, Lauffenburger DA.
    Integrated mechanistic and data-driven modelling for multivariate analysis of signalling pathways
    Journal of the Royal Society Interface 2006 Aug 22;3(9):515-26.
    [pdf]

  • Harjunpää A, Taskinen M, Nykter M, Karjalainen-Lindsberg ML, Nyman H, Monni O, Hemmer S, Yli-Harja O, Hautaniemi S, Meri S, Leppä S.
    Differential gene expression in non-malignant tumor microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP
    British Journal of Haematology 2006 Oct;135(1):33-42.
    [pdf]

  • Lähdesmäki H, Hautaniemi S, Shmulevich I, Yli-Harja O.
    Relationships between probabilistic Boolean networks and dynamic Bayesian networks as models of gene regulatory networks
    Signal Processing 2006 Apr;86:814-834.
    [pdf]

  • Jaatinen T, Hemmoranta H, Hautaniemi S, Niemi J, Nicorici D, Laine J, Yli-Harja O, Partanen J.
    Global gene expression profile of human cord blood-derived CD133+ cells
    Stem Cells 2006 Mar;24(3):631-41.
    [pdf]

  • Berger JA, Hautaniemi S, Mitra SK, Astola J.
    Jointly analyzing gene expression and copy number data in breast cancer using data reduction models
    IEEE/ACM Transactions on Computational Biology and Bioinformatics 2006 Jan;3(1):2-16.
    [pdf]

  • Arango D, Laiho P, Kokko A, Alhopuro P, Sammalkorpi H, Salovaara R, Nicorici D, Hautaniemi S, Alazzouzi H, Mecklin JP, Järvinen H, Hemminki A, Astola J, Schwartz S Jr, Aaltonen LA.
    Gene expression profiling predicts recurrence in Dukes C colorectal cancer
    Gastroenterology 2005 Sep;129(3):874-884.
    [pdf]

  • Hautaniemi S, Kharait S, Iwabu A, Wells A, Lauffenburger DA.
    Modeling of signal-response cascades using decision tree analysis
    Bioinformatics 2005 May;21(9):2027-2035.
    [pdf]

  • Liang WS, Maddukuri A, Teslovich TM, de la Fuente C, Agbottah E, Dadgar S, Kehn K, Hautaniemi S, Pumfery A, Stephan DA, Kashanchi F.
    Therapeutic targets for HIV-1 infection in the host proteome
    Retrovirology 2005 Mar 21;2(1):20.
    [pdf]

  • Berger JA, Hautaniemi S, Järvinen AK, Edgren H, Mitra SK, Astola J.
    Optimized LOWESS normalization parameter selection for DNA microarray data
    BMC Bioinformatics 2004 Dec 9;5(1):194.
    [pdf]

  • Mahlamäki EH, Kauraniemi P, Monni O, Wolf M, Hautaniemi S, Kallioniemi A.
    High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer
    Neoplasia 2004 Sep-Oct;6(5):432-439.
    [pdf] [supplementary page]

  • Huusko P, Ponciano-Jackson D, Wolf M, Kiefer JA, Azorsa DO, Tuzmen S, Weaver D, Robbins C, Moses T, Allinen M, Hautaniemi S, Chen Y, Elkahloun A, Basik M, Bova GS, Bubendorf L, Lugli A, Sauter G, Schleutker J, Ozcelik H, Elowe S, Pawson T, Trent JM, Carpten JD, Kallioniemi OP, Mousses S.
    NMD microarray analysis reveals mutations of the EphB2 gene in human prostate cancer
    Nature Genetics 2004 Sep;36(9):979-983.
    [pdf]

  • Wolf M, Mousses S, Hautaniemi S, Karhu R, Huusko P, Allinen M, Elkahloun A, Monni O, Chen Y, Kallioniemi A, Kallioniemi OP.
    High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: Impact on gene expression
    Neoplasia 2004 May-Jun;6(3):240-247.
    [pdf]

  • Järvinen AK, Hautaniemi S, Edgren H, Auvinen P, Saarela J, Kallioniemi OP, Monni O.
    Are data from different cDNA and oligonucleotide microarray platforms comparable?
    Genomics 2004 Jun;84(6):1164-1168.
    [pdf] [supplementary page]

  • Hautaniemi S, Ringnér M, Kauraniemi P, Autio R, Edgren H, Yli-Harja O, Astola J, Kallioniemi A, Kallioniemi OP.
    A strategy for identifying putative causes of gene expression variation in human cancers
    Journal of the Franklin Institute 2004 Jan-Mar;341(1-2):77-88.
    [pdf]

  • Kauraniemi P, Hautaniemi S, Autio R, Astola J, Monni O, Elkahloun A, Kallioniemi A.
    Effects of Herceptin treatment on global gene expression patterns in HER2 amplified and non-amplified breast cancer cell lines
    Oncogene 2004 Jan;23(4):1010-1013.
    [pdf]

  • Hautaniemi S, Edgren H, Vesanen P, Wolf M, Järvinen AK, Yli-Harja O, Astola J, Kallioniemi O, Monni O.
    A novel strategy for microarray quality control using Bayesian networks
    Bioinformatics 2003 Nov;19(16):2031-2038.
    [pdf] [supplementary page]

  • Mousses S, Caplen NJ, Cornelison R, Weaver D, Basik M, Hautaniemi S, Elkahloun AG, Lotufo RA, Choudary A, Dougherty ER, Suh E, Kallioniemi O.
    RNAi microarray analysis in cultured mammalian cells
    Genome Research 2003 Oct;13(10):2341-2347.
    [pdf]

  • Autio R, Hautaniemi S, Kauraniemi P, Yli-Harja O, Astola J, Wolf M, Kallioniemi A.
    CGH-Plotter: MATLAB toolbox for CGH-data analysis
    Bioinformatics 2003 Sep;19(13):1714-1715.
    [pdf] [supplementary page]

  • Hautaniemi S, Yli-Harja O, Astola J, Kauraniemi P, Kallioniemi A, Wolf M, Ruiz J, Mousses S, Kallioniemi OP.
    Analysis and visualization of gene expression microarray data in human cancer using self-organizing maps
    Machine Learning 2003 Jul;52(1-2):45-66.
    [pdf]

  • Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, Ringnér M, Sauter G, Monni O, Elkahloun A, Kallioniemi OP, Kallioniemi A.
    Impact of DNA amplification on gene expression patterns in breast cancer
    Cancer Research 2002 Nov;62(21):6240-6245.
    [pdf]

  • Monni O, Hautaniemi S, Kallioniemi OP.
    Gene chip technique and associated bioinformatics
    Duodecim 2002 Jun;118(11):1157-1166.
    [pdf] (In Finnish only)

Back